Pfizer (FRA:PFE) Interest Expense : €-2,048 Mil (TTM As of Dec. 2023)

View and export this data going back to 1951. Start your Free Trial

What is Pfizer Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pfizer's interest expense for the three months ended in Dec. 2023 was € -631 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-2,048 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pfizer's Operating Income for the three months ended in Dec. 2023 was € -1,807 Mil. Pfizer's Interest Expense for the three months ended in Dec. 2023 was € -631 Mil. Pfizer did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pfizer Interest Expense Historical Data

The historical data trend for Pfizer's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Interest Expense Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1,415.70

-1,191.08

-1,142.54

-1,168.67

-2,025.65

Pfizer Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-295.47	-297.01	-468.88	-651.22	-630.90

Pfizer Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2,048 Mil.

Pfizer (FRA:PFE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pfizer's Interest Expense for the three months ended in Dec. 2023 was €-631 Mil. Its Operating Income for the three months ended in Dec. 2023 was €-1,807 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was €55,478 Mil.

Pfizer's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Pfizer did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Pfizer (FRA:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (FRA:PFE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.